Medical Weight Loss for Alexandria, Virginia Residents

Alexandria, Virginia residents get physician-supervised weight loss by telehealth from New Hope Weight Loss: a $119 doctor review, then compounded semaglutide from $166/month or tirzepatide from $233/month.

Physician-supervised GLP-1 programs from $166/month, serving Alexandria through telehealth from our Costa Mesa, California clinic. Doctor review $119. Over 5,400 patients treated.

Two GLP-1 options, shipped to Alexandria: compounded semaglutide shares its active ingredient with Wegovy and Ozempic, and tirzepatide with Mounjaro and Zepbound. These are not FDA-approved and not brand-identical; Dr. Sharma helps Virginia patients choose. Doctor review just $119 (medication separate).

Why Alexandria Residents Choose New Hope Weight Loss

At New Hope Weight Loss, every case in Alexandria is overseen by a named physician, Dr. Anjmun Sharma, MD. You are not handed off to a rotating panel of strangers or a faceless intake bot. Dr. Sharma reviews your history, signs off on your plan, and stays accountable for it. That single point of medical responsibility is rare in telehealth, and it is the reason so many people across Virginia trust us to guide a serious decision about their health.

Alexandria is served by telemedicine from our Costa Mesa, California clinic. The same physician-supervised semaglutide and tirzepatide programs are available by secure video, with medication shipped to your door.

Your zip code in Alexandria, Virginia does not change the medicine or the doctor, only the way you connect, since Dr. Anjmun Sharma supervises every patient remotely from Costa Mesa. We care for patients throughout Old Town, Del Ray, and the greater Northern Virginia area. There is no distance surcharge for living outside Costa Mesa, and we accept HSA, FSA, Klarna, and Affirm to make starting easier across Virginia.

Distance simply stops mattering here, since every appointment for Alexandria residents takes place over secure video rather than in a waiting room. Compounded semaglutide shares its active ingredient with Wegovy and Ozempic, and for Alexandria patients it starts at $166 per month, billed separately. New Hope Weight Loss serves patients throughout Virginia entirely by telehealth from our Costa Mesa, California clinic, delivering physician-supervised GLP-1 programs without an office visit.

GLP-1 Weight Loss Programs Available

The 90-Day Metabolic Reset (Semaglutide)

Think of this as a focused three-month plan. Semaglutide carries the same active ingredient as Wegovy and Ozempic, and the branded versions averaged about 15 to 17 percent body-weight loss in trials. Pricing is from $166/mo, with the full 90 days at $499, and Dr. Sharma adjusts your dose along the way. Compounded semaglutide is not FDA-approved, not brand-identical, and individual results vary.

Advanced Program (Tirzepatide)

From $233/mo, tirzepatide engages two metabolic pathways, GLP-1 and GIP. Trials of the branded drug reached up to 22.5 percent loss at higher qualifying doses, a best-case figure rather than the norm. Shares an active ingredient with Mounjaro and Zepbound.

Doctor review: $119. Medication billed separately. HSA, FSA, Klarna, and Affirm welcome for Alexandria telehealth patients.

How Telehealth Works for Alexandria

Step 1. Complete the online intake and weight-history quiz from your phone or laptop.

Step 2. Dr. Sharma reviews everything and meets you over secure video, typically within 48 hours, to confirm whether compounded semaglutide or tirzepatide makes sense for you.

Step 3. If appropriate, a state-licensed 503(a) pharmacy ships your medication to your Alexandria home in insulated cold-pack packaging.

Step 4. You check in by video for follow-ups, so adjusting your dose never means a drive across .

Frequently Asked Questions, Alexandria

Where is the closest New Hope Weight Loss to Alexandria?

Our clinic is physically located in Costa Mesa, California, and it is the only one we operate. Distance is not a barrier, though, because Alexandria, Virginia patients are cared for through telehealth. During a video consultation, Dr. Anjmun Sharma reviews your situation and confirms your eligibility for a compounded GLP-1 plan.

Is in-person attendance required for patients from Alexandria?

It is not. We run a complete telehealth model, so people in Alexandria handle everything from home. Your appointment with Dr. Sharma, your paperwork, and your follow-ups are all online. Approved medication is shipped to Alexandria using cold-pack insulation that keeps it stable until it reaches you.

What should a Alexandria patient budget for care?

The visit with the physician is $119. Semaglutide starts at $166 monthly or $499 for the 90-day program, and tirzepatide at $233 monthly. The drug is billed apart from the consult. We take HSA, FSA, Klarna, and Affirm, and Alexandria patients are not charged any extra distance fee.

What areas of Alexandria do you serve?

We serve patients from across Alexandria by telehealth, including Old Town, Del Ray, and the greater Northern Virginia area.

How does compounded medication compare on cost for Alexandria patients?

Compounded semaglutide from $166/month and tirzepatide from $233/month are a fraction of typical brand-name cash prices. Alexandria patients see flat pricing up front, and compounded semaglutide and tirzepatide are not FDA-approved or brand-identical, which Dr. Sharma reviews with you.

Alexandria Residents, Get Started Today

Doctor review $119. Semaglutide from $166/mo. Tirzepatide from $233/mo. Medication separate.

Start My Journey →

New Hope Weight Loss | clinic at 1503 South Coast Drive, Suite 322, Costa Mesa, CA 92626 | (657) 837-3342 | Serving Alexandria, Virginia by telehealth. Telehealth availability and eligibility are confirmed during the medical consultation.

Wegovy® and Ozempic® are registered trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. New Hope Weight Loss is not affiliated with or endorsed by these companies. Compounded semaglutide and tirzepatide are prepared by licensed U.S. pharmacies and are not FDA-approved, not brand-identical, and not reviewed by the FDA for safety, effectiveness, or quality.